SUBSCRIBE
SUBSCRIBE

Diagnostics

Drug Development
COVID-19 Long-Hauler Therapy Space Beginning to Take Shape
While the space is just beginning to emerge, therapies for long-haul COVID-19 patients are still very much an unmet need.
February 9, 2021
 · 
7 min read
 · 
Heather McKenzie
Drug Development
2021 Biopharma Update on the Novel Coronavirus: February 9
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for February 9, 2021.
February 8, 2021
 · 
6 min read
 · 
BioSpace Editorial Staff
Drug Development
2021 Biopharma Update on the Novel Coronavirus: February 2
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for February 2, 2021.
February 2, 2021
 · 
5 min read
 · 
BioSpace Editorial Staff
Bumble Dee/Shutterstock
Business
J.P. Morgan: Will Biotech’s Virtual 2021 Launch Become the New Reality?
At the annual J.P. Morgan conference, the biotech industry launched its encore to a wildly successful 2020 – virtually. And, as is becoming the common scenario, attendees found both pros and cons to our new (temporary?) reality.
January 27, 2021
 · 
5 min read
 · 
Heather McKenzie
Drug Development
2021 Biopharma Update on the Novel Coronavirus: January 26
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for January 26, 2021.
January 26, 2021
 · 
4 min read
 · 
BioSpace Editorial Staff
Drug Development
2021 Biopharma Update on the Novel Coronavirus: January 19
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for January 19, 2021.
January 19, 2021
 · 
6 min read
 · 
BioSpace Editorial Staff
Drug Development
2021 Biopharma Update on the Novel Coronavirus: January 12
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for January 12, 2021.
January 12, 2021
 · 
4 min read
 · 
BioSpace Editorial Staff
Policy
New COVID-19 Mutation Could Mess Up Tests, Trigger False Negatives
On Friday, the U.S. Food and Drug Administration (FDA) issued an official alert stating that it could trigger false negatives in COVID-19 tests.
January 11, 2021
 · 
2 min read
 · 
Heather McKenzie
Genetown
Glympse Advances BioSensors for NASH and Other Protease-Mediated Diseases
Glympse Bio’s tunable biosensors are poised to be a game-changing diagnostic tool in 2021.
January 6, 2021
 · 
4 min read
 · 
Gail Dutton
Drug Development
2021 Biopharma Update on the Novel Coronavirus: January 5
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for January 5, 2021.
January 4, 2021
 · 
3 min read
 · 
BioSpace Editorial Staff
Load More
PRESS RELEASES
Press Releases
C2N Diagnostics’ PrecivityAD2™ Blood Test Receives MHRA Medical Device Certification in the United Kingdom
February 25, 2025
 · 
4 min read
Press Releases
Landmark Seqfirst-neo Study Showcases the Significant Impact of Genomic Testing in the NICU, Revealing Gaps in Current Protocols
February 25, 2025
 · 
6 min read
Press Releases
Bracco and the European Society of Radiology build on long-standing partnership at ECR 2025 through new campaign to advance innovative and sustainable approaches in radiology
February 21, 2025
 · 
5 min read
Press Releases
Ezra Announces New FDA Clearance, Enhancing the Capabilities of Its Full-Body Scan Technology
February 21, 2025
 · 
2 min read
Press Releases
The 7 Major Lymphedema Markets are Expected to Exhibit a CAGR Of 7.31% During 2025-2035, impelled by Advancements in Early Detection and Diagnostic Technologies
February 20, 2025
 · 
8 min read
Press Releases
The 7 Major Immune Thrombocytopenia (ITP) Markets are Expected to Exhibit a CAGR Of 3.82% During 2025-2035, impelled by Advancements in Early Detection and Diagnostic Technologies
February 20, 2025
 · 
11 min read
Press Releases
Acute Respiratory Syndrome Coronavirus Infection Market Size to Reach US$ 79.0 Billion by 2035, Impelled by Technological Advancements in Diagnostics
February 19, 2025
 · 
12 min read
Press Releases
Sialidosis Market Expected to Exhibit a CAGR of 7.4% during 2025-2035, Impelled by Research and Development in Enzyme Replacement Therapies (ERT)
February 19, 2025
 · 
8 min read
Press Releases
Sciatica Market Size to Reach USD 3.4 Billion by 2035, Impelled by Advancements in Regenerative Therapies
February 19, 2025
 · 
9 min read
Press Releases
Proliferative Vitreoretinopathy Market Size to Reach USD 4.1 Billion by 2035, Impelled by Increased Investment in Ophthalmology and Healthcare Infrastructure
February 19, 2025
 · 
11 min read
Press Releases
Primary Immune Deficiency Market Size to Reach USD 9.9 Billion by 2035, Impelled by Advancements in Targeted Therapies
February 19, 2025
 · 
12 min read
Press Releases
The Primary Gastric Lymphoma Market Size to Reach USD 9.3 Billion by 2035, Impelled by Advancements in Targeted Drug Therapies
February 19, 2025
 · 
8 min read
Press Releases
Oncocytoma Market Expected to Exhibit a CAGR of 5.24% during 2025-2035, Impelled by Emerging Role of Molecular Diagnostics
February 19, 2025
 · 
9 min read
Press Releases
Foundation Medicine Collaborates with Sumitomo Pharma America to Advance Investigational Treatment for Patients with Acute Leukemia with NPM1 Mutations or KMT2A Rearrangements Using the FoundationOne®Heme Platform
February 19, 2025
 · 
4 min read
Press Releases
Anbio Biotechnology Announces Pricing of Initial Public Offering
February 19, 2025
 · 
5 min read
Press Releases
U.S. Next Generation Cancer Diagnostics Market Size to Hit USD 11,052 Million by 2034
February 18, 2025
 · 
1 min read
Press Releases
Acute Lung Injury Market Size to Reach USD 4.9 Billion by 2035, Impelled by Advancements in Early Detection
February 18, 2025
 · 
7 min read
Press Releases
Enlitic and GE HealthCare to Collaborate to Redefine Imaging Data Migration and Cloud Solutions for Enterprise Imaging
February 17, 2025
 · 
5 min read
Press Releases
Small Lymphocytic Lymphoma Market Expected to Grow at a CAGR of 2.9% during 2025-2035, Impelled by Advancements in Targeted Drug Therapies
February 14, 2025
 · 
11 min read
Press Releases
Sly Syndrome Market Size to Reach USD 969.2 Million by 2035, Impelled by Increased Focus on Rare Disease Treatment
February 14, 2025
 · 
9 min read
Load More